At the same time, there are much higher frequencies of senescent phenotype TEMRA+ CD57+ CD8+ T cells but reduced antiviral cytokine production and cytotoxicity of CD4+, CD8+ T, and NK cells in patients with COVID-19. This evidence concerns the gene CD8A and COVID-19.